
Breakthrough Treatment Offers New Hope Against Most Common Childhood Cancer
A groundbreaking study from the University of Cambridge suggests a novel therapeutic combination that could revolutionize the treatment landscape of B-cell acute lymphoblastic leukemia (B-ALL), the most common childhood cancer and one that poses …